DBV Technologies SA (DBVT)
0.682
-0.01
(-1.08%)
USD |
NASDAQ |
Apr 26, 16:00
0.6811
0.00 (0.00%)
After-Hours: 20:00
DBV Technologies Cash from Operations (TTM): -79.65M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -79.65M |
| September 30, 2023 | -89.85M |
| June 30, 2023 | -90.33M |
| March 31, 2023 | -75.02M |
| December 31, 2022 | -55.67M |
| September 30, 2022 | -50.57M |
| June 30, 2022 | -53.47M |
| Date | Value |
|---|---|
| March 31, 2022 | -73.52M |
| December 31, 2021 | -108.24M |
| September 30, 2021 | -122.98M |
| June 30, 2021 | -142.26M |
| March 31, 2021 | -152.13M |
| December 31, 2020 | -165.61M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-165.61M
Minimum
Dec 2020
-50.57M
Maximum
Sep 2022
-96.87M
Average
-89.85M
Median
Sep 2023
Cash from Operations (TTM) Benchmarks
| Edap TMS SA | -15.89M |
| Cellectis SA | -65.68M |
| Biophytis SA | -13.97M |
| Genfit SA | -- |
| Adaptimmune Therapeutics PLC | -140.88M |